Celmatix Information

View Top Employees from Celmatix

Celmatix Therapeutics is a preclinical-stage women’s health biotech focused on advancing groundbreaking therapeutics for women’s health. With its growing pipeline of innovative drug programs including an AMHR2 agonist program focused on ovarian aging, an oral FSH for infertility, and a JNK inhibitor program for endometriosis, Celmatix Therapeutics is addressing areas of high unmet need by developing the next generation of interventions and pioneering advancements in women’s health. For more information, visit the company’s website at www.celmatix.com.

Website	http://www.celmatix.com
Revenue	$21.8 million
Funding	$54.1 million
Employees	15 (7 on RocketReach)
Founded	2009
Address	14 Wall Street, New York, New York 10005, US
Phone	+1 646-389-0245
Technologies	JavaScript , HTML , Twitter +38 more (view full list)
Industry	Biotechnology, Fertility, Biotechnology Research, Business Services General, Reproductive Biology and Medicine, Business Services, Science and Engineering, Other Healthcare Technology Systems, Genomics, Bioinformatics, Health Care, Data Analytics, Genetics, Biotech, Women's health, Infertility
Web Rank	3 Million
Keywords	Womens Health, Fertility, Reproductive Health, Preclinical Stage, Infertility, Polycystic Ovary Syndrome, Biotech, Female Reproductive Health, Pcos, Drug Development, Contraception, Molecular Biology
Competitors	Quest Diagnostics, Labcorp, Natera, Ancestry, Myriad Genetics, GeneDx, Invitae, Fulgent Genetics, Color, 23andMe Inc +31 more (view full list)
SIC	SIC Code 87 Companies, SIC Code 873 Companies
NAICS	NAICS Code 54 Companies, NAICS Code 541714 Companies, NAICS Code 54171 Companies, NAICS Code 5417 Companies, NAICS Code 541 Companies